Alantolactone Suppresses Human Osteosarcoma Through the PI3K/AKT Signaling Pathway
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2019.10882
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2019
Authors
Publisher
Spandidos Publications